Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Bayer Aktienges Ads (BAYRY)

Bayer Aktienges Ads (BAYRY)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 72,291,352
  • Shares Outstanding, K 3,730,204
  • Annual Sales, $ 46,751 M
  • Annual Income, $ 2,002 M
  • 60-Month Beta 1.06
  • Price/Sales 1.55
  • Price/Cash Flow 5.13
  • Price/Book 1.46
  • Price/Earnings ttm 10.71
  • Earnings Per Share ttm 1.81
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 11/12/19
  • Annual Dividend & Yield 0.55 (2.80%)
  • Most Recent Dividend 0.546 on 04/29/19
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate 0.34
  • Number of Estimates 1
  • High Estimate 0.34
  • Low Estimate 0.34
  • Prior Year 0.31
  • Growth Rate Est. (year over year) +9.68%

Price Performance

See More
Period Period Low Period High Performance
1-Month
17.9500 +7.91%
on 10/22/19
19.9080 -2.70%
on 11/06/19
+1.3300 (+7.37%)
since 10/14/19
3-Month
16.5000 +17.39%
on 10/02/19
19.9080 -2.70%
on 11/06/19
+1.6700 (+9.44%)
since 08/14/19
52-Week
14.6100 +32.58%
on 05/31/19
20.6900 -6.38%
on 03/06/19
+1.1200 (+6.14%)
since 11/14/18

Most Recent Stories

More News
AVEO Pharmaceuticals (AVEO) Q3 Earnings & Revenues Top Mark

AVEO Pharmaceuticals (AVEO) rides high on both earnings and revenue beat in the third quarter. Shares rise.

BMY : 58.25 (-0.92%)
AZN : 47.37 (-0.94%)
BAYRY : 19.3800 (unch)
AVEO : 0.64 (-9.86%)
Bristol-Myers' Opdivo/Yervoy sBLA for HCC Gets Priority Review

Bristol-Myers' (BMY) label expansion application for Opdivo plus Yervoy combo regimen to include patients with hepatocellular carcinoma, a form of liver cancer, makes progress.

MRK : 84.55 (-0.32%)
BMY : 58.25 (-0.92%)
BAYRY : 19.3800 (unch)
RHHBY : 37.3200 (-0.74%)
Global Bleeding Disorders Therapeutics Market 2020-2024 | Evolving Opportunities with Baxter International Inc. & Bayer AG | Technavio

The global bleeding disorders therapeutics market size is poised to grow by USD 4.32 billion during 2020-2024, according to a new report by Technavio, progressing at a CAGR of close to 7% during the forecast...

BAYRY : 19.3800 (unch)
The Zacks Analyst Blog Highlights: Berkshire Hathaway, Adobe Systems, BHP, BlackRock and Aktiengesellschaft

The Zacks Analyst Blog Highlights: Berkshire Hathaway, Adobe Systems, BHP, BlackRock and Aktiengesellschaft

BAYRY : 19.3800 (unch)
ADBE : 294.66 (+0.38%)
BLK : 484.75 (-0.17%)
BRK.B : 219.50 (-0.12%)
BHP : 49.91 (+0.40%)
Top Research Reports for Berkshire Hathaway, Adobe & BHP

Top Research Reports for Berkshire Hathaway, Adobe & BHP

BRK.B : 219.50 (-0.12%)
BLK : 484.75 (-0.17%)
BHP : 49.91 (+0.40%)
BAYRY : 19.3800 (unch)
AVGO : 308.95 (-1.50%)
ADBE : 294.66 (+0.38%)
Ultragenyx (RARE) Reports Wider-Than-Expected Loss in Q3

Ultragenyx (RARE) reports wider-than-expected loss and misses sales estimates in the third quarter of 2019.

BAYRY : 19.3800 (unch)
AVEO : 0.64 (-9.86%)
RARE : 36.79 (-1.31%)
ASLN : 0.44 (+18.92%)
Regeneron's (REGN) Q3 Earnings Beat on Dupixent Strength

Regeneron (REGN) beats on Q3 earnings and sales on the back of solid demand for ophthalmology drug, Eylea, and asthma drug, Dupixent.

BAYRY : 19.3800 (unch)
SNY : 45.00 (-1.36%)
ALNY : 90.48 (-0.11%)
REGN : 338.47 (-2.82%)
Is a Beat in the Cards for Regeneron (REGN) Q3 Earnings?

Investors will focus on the performance of Eylea and Dupixent along with other pipeline updates, when Regeneron (REGN) reports third-quarter 2019 results.

AGN : 182.47 (+0.48%)
BAYRY : 19.3800 (unch)
REGN : 338.47 (-2.82%)
JAZZ : 133.94 (+0.47%)
Watermelon Seeds Market 2019-2023| Evolving Opportunities with BASF SE and Bayer AG | Technavio

Technavio has been monitoring the global watermelon seeds market since 2017 and the market is poised to grow by USD 1.02 billion during 2019-2023, progressing at a CAGR of almost 14% during the forecast...

BAYRY : 19.3800 (unch)
Novartis (NVS) Q3 Earnings & Sales Beat Estimates, Up Y/Y

Novartis (NVS) beats sales estimates in the third quarter of 2019, driven by robust performance of key drugs and increased contribution from new launches.

GSK : 43.84 (-1.84%)
BAYRY : 19.3800 (unch)
NVS : 89.50 (-0.40%)
REGN : 338.47 (-2.82%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More Share

Trade BAYRY with:

Key Turning Points

2nd Resistance Point 19.5533
1st Resistance Point 19.4667
Last Price 19.3800
1st Support Level 19.3067
2nd Support Level 19.2333

See More

52-Week High 20.6900
Last Price 19.3800
Fibonacci 61.8% 18.3674
Fibonacci 50% 17.6500
Fibonacci 38.2% 16.9326
52-Week Low 14.6100

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar